Drug Trial Radar · NCT07333183
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Last checked: Nov 19, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
20
Planned (sponsor's estimate)
Start
Dec 23, 2025
Primary completion
Dec 2026
Study completion Jan 2028
Sponsor
- Lead sponsor
- Pulmovant, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2, open-label, multi-center clinical study to evaluate the safety and tolerability of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD) on a background inhaled treprostinil.
Conditions
- Pulmonary Hypertension
- Interstitial Lung Disease (ILD)
- Lung Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Fibrosis
Interventions
inhaled mosliciguatDrug
Dose level 1, 2, or 3 for inhalation
Dry Powder InhalerDevice
Dry powder inhaler for mosliciguat delivery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and nature of participant TEAEs, SAEs, and AEs leading to discontinuationTime frame: Baseline, Week 16
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
Clinical Research Site
Santa Barbara, California · Recruiting
Clinical Research Site
Torrance, California · Recruiting
Clinical Research Site
Kissimmee, Florida · Recruiting
Clinical Research Site
Chicago, Illinois · Recruiting
Clinical Research Site
Kansas City, Kansas · Recruiting
Clinical Research Site
Boston, Massachusetts · Recruiting
Clinical Research Site
Ann Arbor, Michigan · Recruiting
Clinical Research Site
Detroit, Michigan · Recruiting
Clinical Research Site
Albuquerque, New Mexico · Recruiting
Clinical Research Site
Greensboro, North Carolina · Recruiting
Clinical Research Site
Providence, Rhode Island · Recruiting
Clinical Research Site
Charleston, South Carolina · Recruiting
Clinical Research Site
Houston, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.